logo

Galmed Pharmaceuticals Ltd (GLMD) Stock: A Year of Highs and Lows in the Market

CSCO Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Galmed Pharmaceuticals Ltd’s current trading price is -94.71% away from its 52-week high, while its distance from the 52-week low is 4.13%. The stock’s price range for this period has been between $1.21 and $23.80 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.75 million for the day, a number notably lower than the average daily volume of 0.86 million over the last three months.

Galmed Pharmaceuticals Ltd experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $23.80 on 09/17/24, while the lowest price for the same period was registered at $1.21 on 04/08/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Galmed Pharmaceuticals Ltd (GLMD) has experienced a quarterly decline of -57.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.85M and boasts a workforce of 6 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.5288, with a change in price of -1.7300. Similarly, Galmed Pharmaceuticals Ltd recorded 559,615 in trading volume during the last 100 days, posting a change of -57.86%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for GLMD stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

GLMD Stock Stochastic Average

Galmed Pharmaceuticals Ltd’s raw stochastic average for the past 50 days is presently 2.18%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 2.18%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 5.09% and 4.09%, respectively.

GLMD Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -60.50% this year. Over the last six months, there has been a stronger performance of -68.34%. The price of GLMD leaped by -28.83% during the last 30 days period. For the last 5-days stocks have slided -13.70%.

Most Popular